- Home
- LITS vs ZJYL Comparison
LITS vs ZJYL Comparison
Compare LITS & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITS
- ZJYL
- Stock Information
- Founded
- LITS 2000
- ZJYL 2006
- Country
- LITS United States
- ZJYL China
- Employees
- LITS N/A
- ZJYL N/A
- Industry
- LITS Biotechnology: Pharmaceutical Preparations
- ZJYL Industrial Specialties
- Sector
- LITS Health Care
- ZJYL Consumer Discretionary
- Exchange
- LITS Nasdaq
- ZJYL Nasdaq
- Market Cap
- LITS 96.2M
- ZJYL 111.3M
- IPO Year
- LITS N/A
- ZJYL 2023
- Fundamental
- Price
- LITS $2.43
- ZJYL $0.50
- Analyst Decision
- LITS
- ZJYL
- Analyst Count
- LITS 0
- ZJYL 0
- Target Price
- LITS N/A
- ZJYL N/A
- AVG Volume (30 Days)
- LITS 1.3M
- ZJYL 214.2K
- Earning Date
- LITS 11-11-2025
- ZJYL 08-20-2025
- Dividend Yield
- LITS N/A
- ZJYL N/A
- EPS Growth
- LITS N/A
- ZJYL N/A
- EPS
- LITS N/A
- ZJYL 0.01
- Revenue
- LITS N/A
- ZJYL $22,826,624.00
- Revenue This Year
- LITS N/A
- ZJYL N/A
- Revenue Next Year
- LITS N/A
- ZJYL N/A
- P/E Ratio
- LITS N/A
- ZJYL $49.57
- Revenue Growth
- LITS N/A
- ZJYL 13.42
- 52 Week Low
- LITS $1.46
- ZJYL $0.48
- 52 Week High
- LITS $9.00
- ZJYL $2.91
- Technical
- Relative Strength Index (RSI)
- LITS N/A
- ZJYL 32.45
- Support Level
- LITS N/A
- ZJYL $0.56
- Resistance Level
- LITS N/A
- ZJYL $0.60
- Average True Range (ATR)
- LITS 0.00
- ZJYL 0.04
- MACD
- LITS 0.00
- ZJYL -0.00
- Stochastic Oscillator
- LITS 0.00
- ZJYL 16.76
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.